KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Research & Development (2016 - 2025)

Historic Research & Development for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $280.7 million.

  • Edwards Lifesciences' Research & Development rose 1077.35% to $280.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 572.27%. This contributed to the annual value of $1.1 billion for FY2024, which is 935.72% up from last year.
  • Per Edwards Lifesciences' latest filing, its Research & Development stood at $280.7 million for Q3 2025, which was up 1077.35% from $276.2 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Research & Development registered a high of $280.7 million during Q3 2025, and its lowest value of $130.6 million during Q4 2022.
  • In the last 5 years, Edwards Lifesciences' Research & Development had a median value of $243.7 million in 2023 and averaged $242.2 million.
  • In the last 5 years, Edwards Lifesciences' Research & Development plummeted by 4390.03% in 2022 and then soared by 8537.52% in 2023.
  • Over the past 5 years, Edwards Lifesciences' Research & Development (Quarter) stood at $232.8 million in 2021, then crashed by 43.9% to $130.6 million in 2022, then soared by 85.38% to $242.1 million in 2023, then increased by 11.98% to $271.1 million in 2024, then rose by 3.54% to $280.7 million in 2025.
  • Its last three reported values are $280.7 million in Q3 2025, $276.2 million for Q2 2025, and $254.6 million during Q1 2025.